CDMO logo

Avid Bioservices, Inc. (CDMO)

Profile

Full Name

Avid Bioservices, Inc.

Ticker

NASDAQ: CDMO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 4, 1994

Indexes

Not included

Website

https://www.avidbio.com

Employees

371

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$139.91M(-6.27% YoY)

Annual EPS

-$2.23(-54490.24% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    -
    CDMO price value is unknown

    30-Day Relative Volume

    -
    CDMO 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    CDMO price change on Jan 1, 1 is unknown

    Price YTD change

    -
    CDMO price ytd change is unknown

    Price 1-year change

    -
    CDMO price 1-year change is unknown

    Price 3-year change

    -
    CDMO price 3-year change is unknown

    Price Range

    Price All-time high

    $581.88
    CDMO price is currently at an all-time high

    Price 3-year low

    $4.07
    CDMO price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    CDMO market capitalization value is unknown

    Market cap 3-year change

    -
    CDMO market capitalization 3-year change is unknown

    Market cap All-time high

    $2.10B
    CDMO market capitalization is currently at an all-time high

    Market cap sector rank

    -
    CDMO market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.27%
    CDMO shares outstanding is up +0.27% year-on-year

    Shares Outstanding 3-Year Change

    +2.89%
    CDMO shares outstanding is up +2.89% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -
    CDMO beta value is unknown

    200-day SMA

    -
    CDMO SMA 200 is unknown

    50-day SMA

    -
    CDMO SMA 50 is unknown

    RSI

    -
    CDMO 14-day relative strength index value is unknown

    Volume

    -
    CDMO 30-day relative volume value is unknown

    ATR

    -
    CDMO average true range value is unknown

    10-day Historical Volatility

    -
    CDMO 10-day historical volatility value is unknown

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $139.91M
    CDMO annual revenue is $139.91 million

    Revenue Analysts estimate

    $163.68M
    CDMO annual revenue is currently -14.52% lower than the consensus analysts' forecast

    Revenue 1-year change

    -6.27%
    CDMO annual revenue is down -6.27% year-on-year

    Revenue Sector rank

    -
    CDMO annual revenue is unknown

    EPS

    EPS

    -$2.23
    CDMO annual earnings per share is -$2.23

    EPS Analysts estimate

    -
    CDMO annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -54490.24%
    CDMO annual earnings per share is down -54490.24% year-on-year

    EPS Sector rank

    -
    CDMO annual earnings per share is unknown

    Profit

    Gross profit

    $7.32M
    CDMO annual gross profit is $7.32 million

    Gross margin

    5.23%
    CDMO annual gross profit margin is 5.23%

    Operating profit

    -$18.68M
    CDMO annual operating income is -$18.68 million

    Operating margin

    -13.35%
    CDMO annual operating profit margin is -13.35%

    Net income

    -$140.75M
    CDMO annual net profit is -$140.75 million

    Net margin

    -100.60%
    CDMO annual net profit margin is -100.60%

    Expenses

    Total expenses

    $158.59M
    CDMO annual total expenses is $158.59 million

    Operating expenses

    $26.00M
    CDMO annual total operating expenses is $26.00 million

    Cost of goods sold

    $132.59M
    CDMO annual cost of goods sold is $132.59 million

    Selling, general & administrative expenses

    $26.00M
    CDMO annual SGA is $26.00 million

    Depreciation and amortization

    $11.11M
    CDMO annual depreciation & amortization is $11.11 million

    Interest expense

    $4.34M
    CDMO annual interest expense is $4.34 million

    Income tax

    $113.83M
    CDMO annual income tax is $113.83 million

    EBIT & EBITDA

    EBIT

    -$22.59M
    CDMO annual earnings before interest & taxes is -$22.59 million

    EBITDA

    -$22.59M
    CDMO annual EBITDA is -$22.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $336.56M
    CDMO annual total assets is $336.56 million

    Non current assets

    $232.56M
    CDMO annual long term assets is $232.56 million

    Current assets

    $104.00M
    CDMO annual total current assets is $104.00 million

    Cash and cash equivalents

    $38.11M
    CDMO annual cash & cash equivalents is $38.11 million

    Accounts receivable

    $16.64M
    CDMO annual accounts receivable is $16.64 million

    Inventory

    $30.38M
    CDMO annual inventory is $30.38 million

    Liabilities

    Total liabilities

    $275.67M
    CDMO annual total liabilities is $275.67 million

    Long term liabilities

    $205.10M
    CDMO annual total long term liabilities is $205.10 million

    Current liabilities

    $70.57M
    CDMO annual total current liabilities is $70.57 million

    Accounts payable

    $20.67M
    CDMO annual accounts payable is $20.67 million

    Debt

    Total debt

    $206.38M
    CDMO annual total debt is $206.38 million

    Total debt 1-year change

    -37.43%
    CDMO annual total debt is down -37.43% year-on-year

    Long term debt

    $205.03M
    CDMO annual long term debt is $205.03 million

    Short term debt

    $1.35M
    CDMO annual short term debt is $1.35 million

    Equity & Capital

    Shareholders equity

    $60.89M
    CDMO annual stockholders equity is $60.89 million

    Book value

    $60.89M
    CDMO annual book value is $60.89 million

    Retained earnings

    -$571.87M
    CDMO annual retained earnings is -$571.87 million

    Working capital

    $33.44M
    CDMO annual working capital is $33.44 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $10.95M
    CDMO annual cash flow from operations is $10.95 million

    Cash from operations 1-year change

    +186.09%
    CDMO annual cash flow from operations is up +186.09% year-on-year

    Cash from investing

    -$31.80M
    CDMO annual cash flow from investing activities is -$31.80 million

    Cash from investing 1-year change

    +59.12%
    CDMO annual cash flow from investing activities is up +59.12% year-on-year

    Cash from financing

    $20.07M
    CDMO annual cash flow from financing activities is $20.07 million

    Cash from financing 1-year change

    +591.73%
    CDMO annual cash flow from financing activities is up +591.73% year-on-year

    CAPEX

    CAPEX

    $31.80M
    CDMO annual capital expenditures is $31.80 million

    CAPEX 1-year change

    -59.12%
    CDMO annual capital expenditures is down -59.12% year-on-year

    Free Cash Flow

    Free cash flow

    -$20.85M
    CDMO annual free cash flow is -$20.85 million

    Free cash flow 1-year change

    +76.96%
    CDMO annual free cash flow is up +76.96% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    5.23%
    CDMO annual gross profit margin is 5.23%

    Operating margin

    -13.35%
    CDMO annual operating profit margin is -13.35%

    Net margin

    -100.60%
    CDMO annual net profit margin is -100.60%

    ROA & ROE

    ROA

    -35.72%
    CDMO annual return on assets is -35.72%

    ROE

    -112.58%
    CDMO annual return on equity is -112.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CDMO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CDMO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    CDMO price to book ratio value is unknown

    PB ratio Sector rank

    -
    CDMO price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    CDMO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CDMO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    CDMO enterprise value value is unknown

    Enterprise value Sector rank

    -
    CDMO enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    CDMO EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    CDMO EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.47
    CDMO annual current ratio is 1.47

    Quick ratio

    1.04
    CDMO annual quick ratio is 1.04

    Leverage

    Debt to equity

    2.52
    CDMO annual debt to equity ratio is 2.52

    Interest coverage ratio

    -5.21
    CDMO annual interest coverage ratio is -5.21

    Risk & Stability

    Piotroski F-Score

    4
    CDMO piotroski f-score is 4

    Altman Z-Score

    -
    CDMO altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Nov 7, 24 William Blair
    Market Perform
    Nov 7, 24 RBC Capital
    Sector Perform
    Sep 10, 24 William Blair
    Market Perform
    Sep 10, 24 Stephens & Co.
    Overweight
    Sep 10, 24 RBC Capital
    Outperform
    Jul 3, 24 RBC Capital
    Outperform
    Apr 30, 24 RBC Capital
    Outperform
    Mar 11, 24 Stephens & Co.
    Overweight
    Mar 7, 24 RBC Capital
    Outperform
    Dec 8, 23 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with CDMO included

    No data
    • What is the ticker symbol for Avid Bioservices, Inc.?
    • Does Avid Bioservices, Inc. pay dividends?
    • What sector is Avid Bioservices, Inc. in?
    • What industry is Avid Bioservices, Inc. in?
    • What country is Avid Bioservices, Inc. based in?
    • When did Avid Bioservices, Inc. go public?
    • Is Avid Bioservices, Inc. in the S&P 500?
    • Is Avid Bioservices, Inc. in the NASDAQ 100?
    • Is Avid Bioservices, Inc. in the Dow Jones?
    • When was Avid Bioservices, Inc.'s last earnings report?
    • When does Avid Bioservices, Inc. report earnings?

    What is the ticker symbol for Avid Bioservices, Inc.?

    The ticker symbol for Avid Bioservices, Inc. is NASDAQ:CDMO

    Does Avid Bioservices, Inc. pay dividends?

    No, Avid Bioservices, Inc. does not pay dividends

    What sector is Avid Bioservices, Inc. in?

    Avid Bioservices, Inc. is in the Healthcare sector

    What industry is Avid Bioservices, Inc. in?

    Avid Bioservices, Inc. is in the Biotechnology industry

    What country is Avid Bioservices, Inc. based in?

    Avid Bioservices, Inc. is headquartered in United States

    When did Avid Bioservices, Inc. go public?

    Avid Bioservices, Inc.'s initial public offering (IPO) was on April 4, 1994

    Is Avid Bioservices, Inc. in the S&P 500?

    No, Avid Bioservices, Inc. is not included in the S&P 500 index

    Is Avid Bioservices, Inc. in the NASDAQ 100?

    No, Avid Bioservices, Inc. is not included in the NASDAQ 100 index

    Is Avid Bioservices, Inc. in the Dow Jones?

    No, Avid Bioservices, Inc. is not included in the Dow Jones index

    When was Avid Bioservices, Inc.'s last earnings report?

    Avid Bioservices, Inc.'s most recent earnings report was on April 24, 2025

    When does Avid Bioservices, Inc. report earnings?

    The date for Avid Bioservices, Inc.'s next earnings report has not been announced yet
    On this page